Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Submitted by
admin
on April 18, 2013 - 10:43am
Source:
Pharmalot
News Tags:
adverse events
diabetes
FDA
Novo Nordisk
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Eli Lilly
Headline:
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Do Not Allow Advertisers to Use My Personal information
